wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q36711007-20BC3080-0758-4C5A-BE07-E9FAA2B8626B
Q36711007-20BC3080-0758-4C5A-BE07-E9FAA2B8626B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36711007-20BC3080-0758-4C5A-BE07-E9FAA2B8626B
Immunological markers and clinical outcome of advanced melanoma patients receiving ipilimumab plus fotemustine in the NIBIT-M1 study.
P2860
Q36711007-20BC3080-0758-4C5A-BE07-E9FAA2B8626B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36711007-20BC3080-0758-4C5A-BE07-E9FAA2B8626B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
9772b94b79f3543f9f5a3f37c3f456e37c69db4e
P2860
Ipilimumab treatment results in an early decrease in the frequency of circulating granulocytic myeloid-derived suppressor cells as well as their Arginase1 production.